1. 1. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584-93;DOI: 10.1038/nrc867.1215435110.1038/nrc867
2. 2. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s-6249s; DOI: 10.1158/1078-0432.CCR-06-0931.10.1158/1078-0432.CCR-06-0931
3. 3. Nielsen OS. Palliative radiotherapy of bone metastases: there is now evidence for the use of single fractions. RadiotherOncol. 1999;52(2):95-6.
4. 4. Eastley N, Newey M, Ashford RU. Skeletal metastases - the role of the orthopaedic and spinal surgeon. SurgOncol. 2012;21(3):216-22; DOI: 10.1016/j.suronc.2012.04.001.10.1016/j.suronc.2012.04.00122554913
5. 5. Walker MS, Miller PJ, Namjoshi M, Houts AC, Stepanski EJ, Schwartzberg LS. Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases. J Med Econ. 2013; 16(1):179-89; DOI: 10.3111/13696998.2012.737883.10.3111/13696998.2012.737883